Genetic sequencing of CEBPA gene in peripheral blood leukocytes (full mutation analysis)
This test checks for mutations in the CEBPA gene, which plays a key role in controlling blood cell development. Mutations here can be linked to certain blood disorders, including acute myeloid leukemia (AML).
["This test helps diagnose or monitor blood cancers by examining genetic changes in your blood cells."]
Key facts at a glance
- LOINC
- 75009-1
- Short code
- CEBPA
- Synonyms
- CEBPA gene Full Mut Anl Bld/T Seq
- Category
- chemistry
- Sample
- whole-blood
- Container
- EDTA (purple-top) tube for whole blood; sterile container for tissue specimens
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- ≥ 0 years
- Method
- sequencing
- CPT
- 81218
- SNOMED
- 426370006
- Specimen volume
- 3-5 mL whole blood; 5-10 mg tissue or bone marrow aspirate in sterile container
- Stability
- Whole blood: Ambient 24 hours, Refrigerated (2-8°C) 7 days; Tissue: Frozen (-20°C or lower) preferred, do not freeze if in formalin. DNA extracted: stable for years at -20°C
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 168–504 hours
- Order
- routine
What Is CEBPA and Why Is It Important?
The CEBPA gene helps regulate how white blood cells develop. When this gene has mutations, it can lead to abnormal blood cell growth, which is often seen in conditions like acute myeloid leukemia (AML).
How Is This Test Performed?
A small blood sample is taken from you, usually from your arm. The blood is then sent to a lab where genetic testing is done to check for mutations in the CEBPA gene. This process involves extracting DNA from your white blood cells and analyzing it for specific changes.
What Does a Positive Result Mean?
A positive result means that your blood cells have mutations in the CEBPA gene that may be associated with certain blood cancers or blood disorders. This finding can help guide treatment decisions, such as targeted therapies or further testing.
What Are the Possible Outcomes?
Your result could show no mutations, a partial mutation, or a full mutation. Each outcome may require different follow-up care, including additional blood tests, closer monitoring, or treatment plans tailored to your genetic profile.
Reference range
No pathogenic mutations detected in the CEBPA gene. Results should be interpreted in conjunction with clinical findings and other laboratory data by a qualified healthcare professional.N/A
No fasting required. Informed consent for genetic testing may be required per institutional policy. Patient should be informed about the purpose, limitations, and potential implications of genetic testing including implications for family members.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
CEBPA mutations are often found in acute myeloid leukemia (AML) and other blood disorders. Detecting these mutations helps doctors confirm a diagnosis, determine the best treatment approach, and monitor disease progression. Early identification can improve treatment outcomes and personalize care plans.
Short name
CEBPA Gene Mutation Test (Blood)
Frequently asked questions
Why might I need this test?
What are the common symptoms linked to CEBPA mutations?
How long does it take to get results?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy